Organization · Type 2 NPI
Genesiscare USA of Florida LLC
Hematology & Oncology Physician · Jacksonville, FL
Practice location
425 N Lee St Ste 104
Jacksonville, FL 32204-1128
Fax (904) 805-7047
Mailing address
2270 Colonial Blvd
Fort Myers, FL 33907-1412
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Hematology (Internal Medicine) Physician | 207RH0000X | None listed |
| Hematology & Oncology Physician Primary | 207RH0003X | None listed |
Hematology & Oncology Physician: An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
2 other providers at this address
Other hematology & oncology physician providers in Jacksonville
- Cancer Specialists LLCHematology & Oncology Physician Jacksonville, FL NPI 1033461546
- Cancer Specialists LLCHematology & Oncology Physician Jacksonville, FL NPI 1306198908
- University of Florida Jacksonville Physicians IncHematology & Oncology Physician Jacksonville, FL NPI 1316107683
- Cancer Specialists LLCHematology & Oncology Physician Jacksonville, FL NPI 1376895888
- Regional Consultants In Hematology Oncology, Inc.Hematology & Oncology Physician Jacksonville, FL NPI 1447247762
- Cancer Specialists, LLCHematology & Oncology Physician Jacksonville, FL NPI 1528323268
- Baptist MD Anderson Cancer Physicians IncHematology & Oncology Physician Jacksonville, FL NPI 1538593124
- Baptist MD Anderson Cancer Physicians IncHematology & Oncology Physician Jacksonville, FL NPI 1558840264
About NPI 1710360508
Genesiscare USA of Florida LLC's National Provider Identifier is 1710360508, issued on Jun 30, 2015. The primary taxonomy on file is Hematology & Oncology Physician (207RH0003X), and the practice location is in Jacksonville, FL. The record was last updated on Nov 3, 2025.